Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy

NCT03217669 is registered in ClinicalTrials.gov with Chao Huang as lead sponsor.

NCT NCT03217669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03217669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy
Lead sponsor
Chao Huang
Phase
Phase 1
Overall status
Unknown status
Start date
February 22, 2018
Completion date
August 1, 2025
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, non-small cell lung cancer (nsclc)